MORRISVILLE, N.C., Nov. 20, 2025 /PRNewswire/ -- Revian, a leader in light therapy for hair regrowth, today announced it has secured up to $13 million, in gross proceeds, in financing led by Flashpoint, an international tech investment firm with approximately $600 million AUM focused on global tech companies. The mix of equity and growth debt funding will support Revian's commercial scale-up, product expansion, and launch of international operations.

Revian's FDA cleared at-home device utilizes patented dual-wavelength red light technology to stimulate nitric oxide production, which (1) inhibits 5-alpha reductase thereby reducing dihydrotestosterone (DHT) levels; (2) enhances scalp microcirculation and (3) reduces scalp inflammation. As a result, Revian's device addresses three well-estab

See Full Page